The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans
Abstract
Patients harbouring Loa loa and/or Mansonella perstans infections, or presenting typical filarial symptomatology, were treated with mebendazole, a drug shown to be efficient in other parasitoses. Of the patients who took the drug during 21 days and provided regular blood samples, 84% showed a significant decrease in their L. loa microfilaraemia and 100% in their M. perstans microfilaraemia, with a concomitant improvement in the clinical manifestations and no side reaction to drug administration. Additionally, the long-lasting effect of the drug (up to day 200 in some cases) may suggest a positive action on the adult worm. Mebendazole may consequently be regarded as a safer alternative to diethylcarbamazine for the treatment of these two parasitoses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mebendazole did not show any difference in efficacy according to different dosage, from 300 mg to 1,500 mg daily, if used for 21 days, and 16 (84.2%) of 19 enrolled patients revealed complete or partial reduction of microfilaremia [234]”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [234]
In the citing paper
“all of 16 cases infected with M. perstans revealed dramatically reduced parasitemia after mebendazole (300–1,500 mg daily for 21–45 days) treatment [234]”
From Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update (2021) · cites this paper as [234]
Citations
Cites
Mebendazole in Enterobiasis Radiochemical and Pilot Clinical Study in 1,278 Subjects
Brugmans, J. P. (1971) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1971.03190030039008 · Cited by 70
Flagged first, then by citations
Research works printed but not linked: 32
- Adolph P. E., 1962, American Journal of Tropical Medicine and Hygiene, 11, 76, 10.4269/ajtmh.1962.11.76 · DOI
- 10.1080/00034983.1982.11687567 · DOI · Paper page
- Bourguignon G. C., 1937, Annales de la Société Belge de Médecine Tropicale, 17, 1
- Brumpt E., 1904, Comptes-rendus de la Sociétéde Biologie, 56, 758
- Cauchie R., 1965, Revue Belge de Pathologie et de Médecine Expérimentale, 31, 232
- Chantin L., 1975, Bulletin de la Société de Pathologie Exotique, 68, 198
- 10.1016/0035-9203(78)90186-4 · DOI
- Dukes D. C., 1968, Central African Journal of Medicine, 14, 21
- Fain A., 1978, WHO Bulletin, 56, 155
- Fain A., 1981, Annales de la Société Belge de Médecine Tropicale, 61, 277
- Fain A., 1973, Bulletin de la Société de Pathologie Exotique, 66, 737
- Foster D. G., 1956, Journal of Tropical Medicine and Hygiene, 59, 212
- 10.1093/clinids/5.5.933 · DOI
- 10.1159/000398096 · DOI
- Heykants J., 1979, Janssen Pharmaceutica Clinical Research Report R 17889/18
- Ive F. A., 1967, Quarterly Journal of Medicine, 36, 495
- Kammerer W. S., 1984, American Journal of Tropical Medicine and Hygiene, 33, 132, 10.4269/ajtmh.1984.33.132 · DOI
- 10.1016/0035-9203(75)90134-0 · DOI · Paper page
- Mak J. W., 1983, Southeast Asian Journal of Tropical Medicine and Public Health, 14, 510
- McQuay R. M., 1966, American Journal of Tropical Medicine and Hygiene, 15, 730, 10.4269/ajtmh.1966.15.730 · DOI
- Richard-Lenoble D., 1980, Bulletin de la Société de Pathologie Exotique, 73, 192
- 10.1016/S0140-6736(81)91235-6 · DOI
- Rodhain F., 1980, Bulletin de la Société de Pathologie Exotique, 73, 182
- Spry C. J. F., 1976, Clinical and Experimental Immunology, 24, 423
- Tai P. C., 1976, Clinical and Experimental Immunology, 24, 415
- 10.1136/jnnp.18.2.103 · DOI
- 10.1016/S0140-6736(85)92350-5 · DOI
- Van Hoegaerden M., 1986, Tropical and Geographical Medicine, 38, 296
- Van Hoegaerden M., 1986, American Journal of Tropical Medicine and Hygiene, 36, 148, 10.4269/ajtmh.1986.35.148 · DOI
- 10.1080/00034983.1982.11687580 · DOI · Paper page
- 10.1016/0035-9203(83)90179-7 · DOI · Paper page
- 10.1016/0035-9203(57)90057-3 · DOI
Cited by
Sorted by citations
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
Chai, J.-Y., Jung, B.-K., & Hong, S.-J. (2021) · The Korean Journal of Parasitology · doi:10.3347/kjp.2021.59.3.189 · Cited by 286
Metadata
- Authors
- Hoegaerden, M. V., Ivanoff, B., Flocard, F., Salle, A., & Chabaud, B.
- Affiliations
- Centre International de Recherches Médicales de Franceville (GA)
- Venue
- Annals of Tropical Medicine & Parasitology
- Publisher
- Informa UK Limited
- Published
- 1987-01
- Volume
- 81
- Issue
- 3
- Pages
- 275-282
- ISSN
- 0003-4983 (ISSN-L)
- 1364-8594
- OpenAlex
- W2410075422
- Cited by
- 44
- References
- 1
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 1 · 2019: 1 · 2016: 3 · 2015: 1 · 2014: 1 · 2012: 1
- FWCI
- 1.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Annals of Tropical Medicine and Parasitology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Parasitic Diseases Research and Treatment
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Research on Leishmaniasis Studies
- Keywords
- mebendazole, Loa loa, Mansonella perstans, filariasis, microfilaremia, antifilarial treatment, drug safety
- MeSH terms
- Adolescent, Adult, Animals, Filariasis, Humans, Loiasis, Mansonelliasis, Mebendazole, Microfilariae, Middle Aged
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review